Article info
PDFArrhythmias and sudden death
Original article
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial
- Correspondence to Jens Cosedis Nielsen, Department of Cardiology, Aarhus University Hospital, Skejby, Palle Juul-Jensens Boulevard 99, Aarhus N 8200, Denmark; jenniels{at}rm.dk
Citation
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial
Publication history
- Received April 10, 2016
- Revised August 4, 2016
- Accepted August 5, 2016
- First published August 26, 2016.
Online issue publication
February 16, 2017
Article Versions
- Previous version (16 February 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/